Mandatory notification of trade - primary insider
ContextVision AB (CONTX) · publisert 22. november 2024 kl. 16:31 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Olof Sandén | Chairman of the Board | acquisition | 15 000 | 4,83 NOK | 8. november 2024 | SE0014731154 | – | llm |
| Gerald Pötzsch | CEO | acquisition | 5 000 | 4,71 NOK | 19. november 2024 | SE0014731154 | – | llm |
| Gerald Pötzsch | CEO | acquisition | 15 000 | 5,26 NOK | 25. september 2024 | SE0014731154 | – | llm |
Meldingstekst
Gerald Pötzsch, CEO of ContextVision, and Olof Sandén, Chairman of the Board of
ContextVision has purchased shares in ContextVision.
With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"),
kindly note the following primary insider share transactions:
Name of listed entity: ContextVision AB
ISIN number: SE0014731154
Stock ticker: CONTX
Name of primary insider: Olof Sandén
Relation to listed entity: Chairman of the Board
Trade: 15.000 shares
Date: 08.11.2024
Average purchase price: NOK 4,83 per share
Primary insider's total shareholdings post-purchase: 18.000 shares
Primary insider's percentage shareholding post-purchase: 0,002%
Name of listed entity: ContextVision AB
ISIN number: SE0014731154
Stock ticker: CONTX
Name of primary insider: Gerald Pötzsch
Relation to listed entity: CEO
Trade: 5.000 shares
Date: 19.11.2024
Average purchase price: NOK 4,71 per share
Primary insider's total shareholdings post-purchase: 55.000 shares
Primary insider's percentage shareholding post-purchase: 0,07%
Name of listed entity: ContextVision AB
ISIN number: SE0014731154
Stock ticker: CONTX
Name of primary insider: Gerald Pötzsch
Relation to listed entity: CEO
Trade: 15.000 shares
Date: 25.09.2024
Average purchase price: NOK 5,26 per share
For more information, please contact:
ir@contextvision.com
About ContextVision
ContextVision is a medical technology software company specialized in
image analysis and artificial intelligence. As the global market leader within
image enhancement, we are a trusted partner to leading manufacturers of
ultrasound, X-ray and MRI equipment around the world. Our expertise is to
develop powerful software products, based on proprietary technology and
artificial intelligence for image-based applications. Our cutting-edge
technology helps clinicians accurately interpret medical images, a crucial
foundation for better diagnosis and treatment. The company, established in 1983,
is based in Sweden with local representation in the U.S., Japan, China and
Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker
CONTX.